Sage So get ready.. The big boys are running out of time.. 14 weeks for Parkinson’s Trial and sleep is an endpoint.. by mid 2019 this deal is done.. that is nothing in holding time..
With Australia getting more data points with patients entering 4th and 5th years( is that right?). Holy Garbanzo Beans a2-73 has saved people from death for years??????
so the volume is held back because big bucks don’t want to battle shorts in a BioPharm that doesn’t have a time frame.. now Anavex has a time frame.. 14 weeks in Parkinsons with a blind.. get ready jack!
Point is volume for this stock follows price not vice a versa.. the price rise will be a result of Market Makers achknowldging the strength and wealth of the buyers by moving the stock up so price will precede volume.
Volume could be retail and how many times do we we have to watch Motley Fool and the Cabal steak retails money?
Just accumulate.. them you don’t have to worry about it..
Market Data 
Markets 
AI
